Rigel Pharmaceuticals RIGL Total debt

Total debt at other companies

AmgenAMGN

$57.3B+2.0%

Agios PharmaceuticalsAGIO

$31.17M-36.1%

Nuvation BioNUVB

$9.52M-83.5%

Zevra Therapeutics, Inc.ZVRA

$1.5M-97.6%

Gyre Therapeutics, Inc.GYRE

$3.42M+145%

Opko HealthOPK

$49.94M-7.5%

FAQ

What is Rigel Pharmaceuticals's total debt?

Rigel Pharmaceuticals (RIGL) reported total debt of $68.36M in Q1 2026.

How has Rigel Pharmaceuticals's total debt changed year-over-year?

Rigel Pharmaceuticals's total debt increased by 5079.1% year-over-year, from $1.32M to $68.36M.

What is the long-term trend for Rigel Pharmaceuticals's total debt?

Over 5 years (2020 to 2025), Rigel Pharmaceuticals's total debt has grown at a 34.0% compound annual growth rate (CAGR), from $19.3M to $83.51M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.